Norges Bank made a bold pharmaceutical play by investing $1.99 billion in Bristol-Myers Squibb, grabbing 1.73% of the company. Other institutional investors like Truist Financial, Inspire Trust, and ...

This was the stock's second consecutive day of gains.

High Yield Stocks to Buy in April. In this article, we are going to take a look at where Bristol-Myers Squibb Company ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

Clayton's clients at S&C have included Barclays Bank, Goldman Sachs Group, Coinbase, Brevan Howard Asset Management and ...

Dividend investing appears to be a simple strategy on the surface, but in reality, it requires a much deeper analysis.

Halozyme Therapeutics (HALO) announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...